Amgen, Q3 2019 Amgen Earnings Conference Call Presentation. Accessed on October 31, 2019.Baselga J, et al. Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer. NEJM. Jan 12;366(…
AbbVie has rigorously defended the IP surrounding its multibillion-dollar product Humira in the United States, resulting in a favorable outcome that is set to prevent biosimilar entry for several…
Biosimilar sponsors are not required to replicate all reference product clinical trials for the approval of their biosimilars via regulatory agencies’ abbreviated pathways. However, they need to…
Spinocerebellar ataxia (SCA) is a heterogeneous group of rare neurodegenerative progressive disorders that primarily affects the cerebellum, and, in some cases, the spinal cord, resulting in the…
Alzheimer’s disease is a progressive and irreversible brain disorder that leads to a decline in cognitive abilities, affecting memory and causing the deterioration of patients’ social and…
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death in China and, thus, a major public health concern. We expect the Chinese COPD therapy market to experience robust…